FDA Approves First Treatment For Peanut Allergy

03:34 EST 3 Feb 2020 | RTTNews

The U.S. Food and Drug Administration has approved the first ever drug to treat peanut allergy, a life-threatening condition mainly for kids. Aimmune Therapeutics Inc.'s Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] can now be used to treat patients aged 4 through 17 years. The Palforzia drug reportedly will list for $890 a month.

Original Article: FDA Approves First Treatment For Peanut Allergy


More From BioPortfolio on "FDA Approves First Treatment For Peanut Allergy"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...